New Era Arrives in Glaucoma Medication, With Transformative Tech
Market Scope estimates pharmaceutical companies
will earn $1.9 billion from glaucoma medications
in the US in 2021, after discounts and rebates, and $4.8 billion worldwide.
Steady Growth, New Technologies Will Drive Retinal Surgery Device Market to $1.36 Billion in 2026
The retinal surgical device market is expected
to total more than $1.14 billion in 2021,
with revenue rising to nearly $1.36 billion in 2026, according to a Market Scope report.
COVID-19 and its impact on eye banking
The COVID-19 pandemic has affected
all areas of medicine, including eye banking.
BLOG: The top ophthalmology research articles from 2020
Despite the COVID-19 pandemic, ophthalmology
research has continued at an exciting pace.
Number of FDA new molecular entity approvals in 2020 similar to 2019
Despite the COVID19 pandemic, the FDA
approved 47 new molecular entities in 2020
including one for ophthalmology, compared with 48 in 2019, according to a speaker at the virtual Ophthalmology Innovation Summit Year in Review meeting.
Cornea Products Market to Grow an Estimated 6.1 Percent Through 2025
Market Scope’s “2020 Cornea Products Market
Report” was published in November